Klotz, L. et al. 2017. Supplementary data: Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer. Canadian Urological Association Journal. 11, 1-2 (Feb. 2017), E62–3. DOI:https://doi.org/10.5489/cuaj.4494.